Focused Investment Sectors Domain Associates specializes in life science investments encompassing pharmaceuticals, diagnostics, and medical devices, highlighting opportunities for suppliers and service providers targeting innovative healthcare solutions.

Strategic International Expansion The firm’s investments in Russia and China via Rusnano and Beijing Elite indicate open channels for partnerships and collaborative technology development in emerging markets.

Recent Growth & Funding Recent investments, including a $6.2M Series A in Seraphina Therapeutics and a $16M Series B in Adynxx, showcase active deal flow, presenting opportunities to engage with portfolio companies expanding their pipelines.

Industry-Leading Experience With nearly 200 years of collective expertise in healthcare and venture capital, Domain Associates is a key stakeholder in pioneering healthcare innovations, suggesting potential for tailored solutions aligned with advanced therapeutic developments.

Financial Profile Managing over $2.4 billion in capital with annual revenues between $10M and $25M, the firm provides a reliable customer base for products and services serving the venture capital-backed biotech and medical device sectors.